Skip to main navigation Skip to search Skip to main content

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients with Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/19 → 1/1/24

Funding

  • National Cancer Institute